Alligator Bioscience AB (ATORX) - Cash Flow Conversion Efficiency

Latest as of June 2026: -4.204x

Based on the latest financial reports, Alligator Bioscience AB (ATORX) has a cash flow conversion efficiency ratio of -4.204x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-13.99 Million ≈ $-1.51 Million USD) by net assets (Skr3.33 Million ≈ $358.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Alligator Bioscience AB worth for the company's overall valuation and market capitalisation.

Alligator Bioscience AB - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Alligator Bioscience AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alligator Bioscience AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alligator Bioscience AB ranked by their cash flow conversion efficiency. Explore Alligator Bioscience AB earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jost AG MU:JOX	N/A
Tijaria Polypipes Limited NSE:TIJARIA	-0.151x
Easson Holdings Ltd PA:MLEAS	N/A
Baronsmead Second Venture Trust Plc LSE:BMD	-0.010x
Galeo Concept SA PA:MLGAL	N/A
Oryx International Growth Fund LSE:OIG	0.001x
UIL Ltd LSE:UTL	0.057x
Westar Resources Ltd AU:WSR	-0.269x

Annual Cash Flow Conversion Efficiency for Alligator Bioscience AB (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alligator Bioscience AB from 2011 to 2025. View Alligator Bioscience AB share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr6.86 Million ≈ $738.14K	Skr-155.99 Million ≈ $-16.79 Million	-22.742x	-1498.03%
2024-12-31	Skr-130.59 Million ≈ $-14.05 Million	Skr-212.43 Million ≈ $-22.86 Million	1.627x	+110.19%
2023-12-31	Skr11.86 Million ≈ $1.28 Million	Skr-189.28 Million ≈ $-20.37 Million	-15.967x	-723.75%
2022-12-31	Skr89.05 Million ≈ $9.58 Million	Skr-172.61 Million ≈ $-18.58 Million	-1.938x	-330.70%
2021-12-31	Skr282.27 Million ≈ $30.38 Million	Skr-127.03 Million ≈ $-13.67 Million	-0.450x	+63.31%
2020-12-31	Skr115.24 Million ≈ $12.40 Million	Skr-141.35 Million ≈ $-15.21 Million	-1.227x	-77.16%
2019-12-31	Skr258.50 Million ≈ $27.82 Million	Skr-178.96 Million ≈ $-19.26 Million	-0.692x	-211.41%
2018-12-31	Skr468.31 Million ≈ $50.40 Million	Skr-104.11 Million ≈ $-11.20 Million	-0.222x	-37.90%
2017-12-31	Skr617.96 Million ≈ $66.50 Million	Skr-99.63 Million ≈ $-10.72 Million	-0.161x	-189.86%
2016-12-31	Skr676.18 Million ≈ $72.77 Million	Skr-37.61 Million ≈ $-4.05 Million	-0.056x	-110.78%
2015-12-31	Skr396.97 Million ≈ $42.72 Million	Skr204.89 Million ≈ $22.05 Million	0.516x	+156.37%
2014-12-31	Skr68.52 Million ≈ $7.37 Million	Skr-62.74 Million ≈ $-6.75 Million	-0.916x	+43.36%
2011-12-31	Skr21.51 Million ≈ $2.31 Million	Skr-34.77 Million ≈ $-3.74 Million	-1.617x	--

About Alligator Bioscience AB

ST:ATORX Sweden Biotechnology

Market Cap

$2.29 Million

Skr21.27 Million SEK

Market Cap Rank

#29958 Global

#680 in Sweden

Share Price

Skr0.02

Change (1 day)

-2.54%

52-Week Range

Skr0.02 - Skr5.40

All Time High

Skr55.78